Latest News

Judge orders new trial, tosses $140M verdict vs AbbVie over Androgel testosterone drug

By Jonathan Bilyk | Jul 5, 2018

A federal judge has knocked down a $140 million verdict against pharmaceutical maker AbbVie, ordering a new trial over a man’s claims AbbVie’s Androgel testosterone replacement therapy drug caused him to suffer a heart attack.

Verdict much lower, but AbbVie wants $3.2M award tossed in second testosterone class action test trial

By Dan Churney | Apr 30, 2018

North Chicago-based drugmaker AbbVie is resisting what it is calling a jury's “confused and inconsistent” $3.2 million verdict, after the company lost a second trial in Chicago federal court – one in which it was ordered to pay $147 million less than the first trial – over a man’s claims AbbVie allegedly failed to warn its product AndroGel could bring on a heart attack.

Development tax incentives, grants could be taxed, but shouldn't dissuade Amazon HQ2 bids, attorney says

By Karen Kidd | Apr 18, 2018

Businesses who take advantage of government financial incentives to expand or build new facilities could face new tax liability under important IRS document issued 10 years ago, but just now coming into its own. However, that should not have much of an impact on the push by Chicago and other U.S. cities and states to land Amazon's HQ2, according to a leading tax expert, attorney and former director of South Carolina's Revenue Department.

Report: Asbestos litigation declines nationwide, slightly in Cook Co., still pervasive in three IL counties

By Jonathan Bilyk and Ann Maher | Mar 23, 2018

As the number of new asbestos lawsuits declined nationally, activity in Illinois’ three hotbeds for asbestos litigation showed few signs of ebbing in 2017, even though the distribution of filing activity has shifted slightly.

From Legal Newsline

Plaintiff lawyers see nationwide settlement as only end for opioid lawsuits

By Daniel Fisher | Mar 7, 2018

SAN FRANCISCO (Legal Newsline) - Plaintiff lawyers meeting in San Francisco last week for a conference on opioid litigation acknowledged that the hundreds of lawsuits they have filed in state and federal court will be difficult to resolve without an unprecedented national settlement whose mechanics are still difficult to predict.

Chicago adds 'Big Three' pharma wholesalers to list of companies being sued over opioid crisis

By Jonathan Bilyk | Mar 6, 2018

As class action litigation continues to grow across the U.S. against the pharmaceutical companies that made opioid prescription painkillers, the city of Chicago has also set its sights in court on three companies it blames for distributing the addictive pills here, saying the companies should be made to pay for allegedly not monitoring the flow of the drugs or halting the suspicious activity at pharmacies and elsewhere that allegedly “fueled” the black market for the drugs.

IL appeals court upholds dismissal of class action challenging Chicago red light camera program law

By Jonathan Bilyk | Feb 14, 2018

Saying state law designates Chicago’s red light and speed camera enforcement programs as something different from ordinary traffic laws, a state appeals court has again handed a defeat to a class action attempting to overthrow the city’s automated traffic citation program, which annually adds millions of dollars in fines from ticketed motorists to the city’s coffers.

From Legal Newsline

Opioid judge doesn't want media to know details of settlement talks

By Daniel Fisher | Feb 9, 2018

CLEVELAND (Legal Newsline) - The judge overseeing multidistrict litigation against opioid manufacturers and distributors has named the teams of lawyers who will try to negotiate a settlement of hundreds of federal lawsuits - a complex task given parallel investigations and litigation by state attorneys general and potentially conflicting goals of private attorneys and their government counterparts.

Union Medical Center, others allegedly failed to prevent woman from slipping and falling

By Louie Torres | Jan 31, 2018

A woman is suing Union Medical Center, Cityscape Landscape LLC, Beef-Boners Union and Chicago Title Land Trust Company for allegedly taking insufficient measures to prevent injuries.

Jury declares Abbvie's Androgel didn't cause man's lung clots, Abbvie didn't falsely market medication

By Jonathan Bilyk | Jan 26, 2018

After split verdicts in two prior trials over alleged harmful side effects and alleged misleading marketing of its testosterone replacement drug led to questionable verdicts worth more than $140 million each, drugmaker Abbvie has scored a clean win in the latest jury review of a plaintiff’s claims over the promotion and health impacts of Androgel.

From Legal Newsline

Usual Suspects: Lawyers used to getting their way in MDL process to lead opioid litigation

By Daniel Fisher | Jan 24, 2018

CLEVELAND (Legal Newsline) - There will be a lot of familiar faces in U.S. District Judge Dan Polster’s courtroom in Cleveland on Jan. 31, when lawyers gather for a hearing on multidistrict litigation against the nation’s opioid manufacturers and distributors.

From Madison County Record

Illinois Supreme Court mulling who gets consolidated opioid cases – Cook Co. or Springfield judge

By Record News | Jan 23, 2018

SPRINGFIELD – Supreme Court Justices must decide whether suits that counties continue filing against opioid manufacturers belong with a judge from Cook County or a judge from Springfield.

Contract: Simmons, Meyers firms to split 25 percent cut of Cook County's take from any opioid lawsuit payment

By Jonathan Bilyk | Jan 12, 2018

Lawyers hired by Cook County to help press the county’s case against drug companies over the proliferation of opioid painkillers stand to pocket at least a quarter of Cook County’s cut of any settlement or dollar amount awarded by a court.

Cook County jumps into legal fray vs pharmaceutical makers, hires Simmons, Meyers & Flowers to sue over 'opioids'

By Jonathan Bilyk | Dec 27, 2017

Cook County, the second largest county in the U.S., has added its name to the ever-growing list of local governments demanding the makers of some of the most prescribed opioid painkillers pay out, saying the companies owe big money for costs the county has incurred in treating painkiller addiction and dealing with its aftermath at the county’s hospitals and other institutions.

Volvo can't escape class action suit due to alleged false marketing over range of hybrid SUV

By Dee Thompson | Dec 12, 2017

A federal judge has ruled that a couple who were upset over their hybrid Volvo’s ability to hold a charge have legitimate claims against Volvo, turning aside the automaker's attempt to again pull the plug on the couple's class action lawsuit.

Judge pauses Chicago opioid lawsuit; judges mull consolidating host of similar cases nationally

By Jonathan Bilyk | Dec 7, 2017

A federal judge has placed on hold the city of Chicago’s lawsuit accusing the makers of prescription painkillers like Oxycontin and Percocet – so-called “opioids” – of falsely marketing their drugs to doctors. defrauding City Hall and other employee health plan administrators, while giving time for a panel of federal judges to decide if the action should be consolidated with other similar lawsuits, brought by cities and others, now pending in other jurisdictions.

DNJ Intermodal Services LLC, others accused of negligence over vehicular accident

By Louie Torres | Nov 24, 2017

A woman has brought a wrongful death suit against Ramiro Rangel Jr., DNJ Intermodal Services LLC, IMC Companies LLC, IMC Global Solutions, National Drayage Services and Atlantic Intermodal Services LLC.

Attorney says 'no chance' that $140 million punitive damages judgment against AbbVie will stand

By Elizabeth Alt | Nov 9, 2017

North Chicago-based drugmaker AbbVie has asked a federal judge to toss out a $140 million verdict against it for allegedly mismarketing its testosterone replacement therapy drug, Androgel. And in the view of a Chicago attorney whose practice focuses on Supreme Court and appellate cases, as well as class actions, there is "no chance" that judgment will be allowed to stand.

Drug maker AbbVie wants to slip from $140M verdict, says jury ignored evidence

By Dan Churney | Nov 6, 2017

North Chicago-based drug company AbbVie is urging a federal judge to trash a verdict ordering it to cough up $140 million, because its testosterone therapy drug AndroGel contributed to a man's heart attack, contending it has no liability because AndroGel was approved by the FDA.

Jury: Abbvie falsely marketed Androgel, owes man who suffered heart attack $140M

By Jonathan Bilyk | Oct 5, 2017

Drugmaker Abbvie has suffered another big loss in court, as a Chicago federal jury has ordered the North Chicago-based pharmaceutical company to pay out $140 million to another man who claimed he had suffered a heart attack as a result of taking Abbvie’s testosterone therapy drug, Androgel.

The Record Network